Infliximab May Reduce Immunogenicity to SARS-CoV-2 Vaccine
Antibody concentrations lower in infliximab-treated individuals with IBD receiving single dose of BNT162b2 or ChAdOx1 nCoV-19 vaccine
Safety of Tranexamic Acid Studied for Orthopedic Surgery in High-Risk Patients
Risk for complications not increased in patients with preexisting comorbidities undergoing hip or knee arthroplasty
CDC Deputy Director Schuchat to Retire
Schuchat joined the CDC in 1988 and had key roles in many health crises
After Setbacks, Sanofi/GSK COVID-19 Vaccine Performs Well in Early Trial
Researchers had to go back to the drawing board after early testing produced only a weak immune response in older people
Most Hospitals Not Publicly Posting Price Data
More than half of hospitals do not have publicly accessible data online, per CMS rule
mRNA Vaccines Effective for Preventing Symptomatic COVID-19
Vaccine effectiveness 82 and 94 percent for single dose, two doses among U.S. health care personnel at 33 sites across 25 U.S. states
Brand-Name Competition for Diabetes Drugs Has Variable Impact on Net Prices
And, one in five generic drugs sold in U.S. experienced price spikes initiated by manufacturers during 2014 to 2017
Ohio Lottery Will Award $1 Million to Five Vaccinated Residents
All Ohio residents who are older than 18 years of age and have received at least one dose of a COVID-19 vaccine are eligible
Systemic Reactogenicity Up With Heterologous COVID-19 Vaccine Doses
More reported feverishness, chills, fatigue, headache, joint pain, malaise, muscle ache after heterologous versus homogenous doses
Risk for Severe Effects Low After SARS-CoV-2 Without Hospitalization
Risks for receiving hospital diagnosis of dyspnea, venous thromboembolism slightly increased, but no increased risk seen for other diagnoses
